Literature DB >> 12467970

Trypanosoma brucei MRE11 is non-essential but influences growth, homologous recombination and DNA double-strand break repair.

Kevin S W Tan1, Simone T G Leal, George A M Cross.   

Abstract

MRE11 is a conserved multi-functional protein that is important for maintaining genomic integrity in yeast and mammalian cells. By database searching, we identified a full-length candidate MRE11 on Trypanosoma brucei chromosome II. We subsequently cloned and sequenced the corresponding gene from the Lister 427 strain. MRE11 is a single copy gene that encodes an 83 kDa protein of 763 amino acids. GFP-MRE11 and Ty1-MRE11 fusion proteins localized to the nucleus of bloodstream and procyclic T. brucei. Interestingly, Ty1-MRE11 associated, to some extent, with telomeres of procyclic but not bloodstream forms. This association appears cell-cycle dependent, with the highest co-localization in G1 cells. We were able to generate an MRE11 null mutant in bloodstream forms, indicating that it is non-essential. However, the null mutant was impaired in homologous recombination, as evidenced by the reduced integration efficiency of transfected DNA. A conditional null mutant, containing a tetracycline-inducible ectopic Ty1-MRE11, exhibited reduced growth and plating efficiency and increased sensitivity to DNA double-strand breaks, induced by methyl methanesulphonate or ionizing radiation, in the absence of tetracycline.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12467970     DOI: 10.1016/s0166-6851(02)00165-2

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  22 in total

Review 1.  The central roles of telomeres and subtelomeres in antigenic variation in African trypanosomes.

Authors:  David Horn; J David Barry
Journal:  Chromosome Res       Date:  2005       Impact factor: 5.239

Review 2.  Focusing homologous recombination: pilin antigenic variation in the pathogenic Neisseria.

Authors:  Laty A Cahoon; H Steven Seifert
Journal:  Mol Microbiol       Date:  2011-08-04       Impact factor: 3.501

Review 3.  DNA repair pathways in trypanosomatids: from DNA repair to drug resistance.

Authors:  Marie-Michelle Genois; Eric R Paquet; Marie-Claude N Laffitte; Ranjan Maity; Amélie Rodrigue; Marc Ouellette; Jean-Yves Masson
Journal:  Microbiol Mol Biol Rev       Date:  2014-03       Impact factor: 11.056

Review 4.  Microbial antigenic variation mediated by homologous DNA recombination.

Authors:  Cornelis Vink; Gloria Rudenko; H Steven Seifert
Journal:  FEMS Microbiol Rev       Date:  2012-01-17       Impact factor: 16.408

5.  Trypanosome telomeres are protected by a homologue of mammalian TRF2.

Authors:  Bibo Li; Amin Espinal; George A M Cross
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

6.  TOPO3alpha influences antigenic variation by monitoring expression-site-associated VSG switching in Trypanosoma brucei.

Authors:  Hee-Sook Kim; George A M Cross
Journal:  PLoS Pathog       Date:  2010-07-08       Impact factor: 6.823

7.  Overview of DNA Repair in Trypanosoma cruzi, Trypanosoma brucei, and Leishmania major.

Authors:  Danielle Gomes Passos-Silva; Matheus Andrade Rajão; Pedro Henrique Nascimento de Aguiar; João Pedro Vieira-da-Rocha; Carlos Renato Machado; Carolina Furtado
Journal:  J Nucleic Acids       Date:  2010-10-04

Review 8.  Molecular mechanisms underlying the control of antigenic variation in African trypanosomes.

Authors:  David Horn; Richard McCulloch
Journal:  Curr Opin Microbiol       Date:  2010-09-29       Impact factor: 7.934

9.  Interactions among Trypanosoma brucei RAD51 paralogues in DNA repair and antigenic variation.

Authors:  Rachel Dobson; Christopher Stockdale; Craig Lapsley; Jonathan Wilkes; Richard McCulloch
Journal:  Mol Microbiol       Date:  2011-05-26       Impact factor: 3.501

10.  Trypanosoma cruzi gene expression in response to gamma radiation.

Authors:  Priscila Grynberg; Danielle Gomes Passos-Silva; Marina de Moraes Mourão; Roberto Hirata; Andrea Mara Macedo; Carlos Renato Machado; Daniella Castanheira Bartholomeu; Glória Regina Franco
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.